logo
  

Autodesk Tightens FY Outlook; Shares Down 10%

Autodesk Inc. (ADSK) Tuesday tightened its outlook for the full year 2022. Shares of the company tanked over 10% in the extended trading hours.

Looking forward to the full year 2022, the software company now expects adjusted earnings of $4.98 to $5.04 per share and revenues of $4.36 billion to $4.38 billion.

Previously, the company expected adjusted earnings of $4.91 to $5.06 per share and revenues of $4.35 billion to $4.39 billion.

Analysts polled by Thomson Reuters currently estimate earnings of $4.99 per share on revenues of $4.37 billion for the year.

For the fourth quarter, the company expects adjusted earnings of $1.41 to $1.47 per share and revenues of $1.19 billion to $1.20 billion. Analysts currently estimate earnings of $1.46 per share on revenues of $1.20 billion.

For the third quarter, the company reported net income of $136.7 million or $0.61 per share, up from $132.2 million or $0.59 per share last year. Excluding items, adjusted earnings for the quarter were $365.0 million or $1.33 per share for the period. Analysts polled by Thomson Reuters had expected earnings of $1.26 per share.

Revenues for the quarter rose 18% to $1.13 billion from $952.4 million last year. Analysts had a consensus revenue estimate of $1.12 billion for the quarter.

ADSK closed Tuesday's trading at $304.00, down $6.48 or 2.09%, on the Nasdaq. The stock further slipped $35.10 or 11.55% in the after-hours trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
RELATED NEWS
Follow RTT